Many kinds of arrhythmias may occur in patients with myocarditis at any stage of the disease.
However, compared to the other clinical presentations, arrhythmic myocarditis has been …

Background Mortality of patients with coronavirus disease 2019 (COVID-19), acute respiratory
distress syndrome (ARDS), and systemic inflammation is high. In areas of pandemic …

A 43-year-old woman presented to the emergency room for a 3-day history of oppressive
chest pain and dyspnoea. Her past medical history was unremarkable. On admission, she had …

We suggest the use of MicroCLOTS (microvascular COVID-19 lung vessels obstructive
thromboinflammatory syndrome) as a new name for severe pulmonary coronavirus disease 2019 …

Background Tocilizumab (TCZ), a humanized monoclonal antibody targeting the interleukin-6
(IL-6) receptor, has been proposed for the treatment of COVID-19 patients; however, …

Background & aims Sarcopenia, a loss of muscle mass, quality and function, which is
particularly evident in respiratory muscles, has been associated with many clinical adverse …

Objectives The aim of our study was to describe the incidence and predictive factors of
secondary infections in patients with coronavirus disease 2019 (COVID-19). Methods This was a …

Background National health-system hospitals of Lombardy faced a heavy burden of
admissions for acute respiratory distress syndromes associated with coronavirus disease (COVID-19…

… Votta 1 , Annalisa Ruggeri 1 , Fabio Ciceri 2 3 , Francesco De Cobelli 2 4 , Moreno Tresoldi
… De Cobelli, Moreno Tresoldi, Lorenzo Dagna, Rinaldo Bellomo and Giovanni Landoni. …

Objectives To assess the safety and efficacy of interleukin (IL)−6 blockade with sarilumab in
patients with severe COVID-19 pneumonia and systemic hyperinflammation. Methods We …